Full Press Release Details
NEW BRUNSWICK, N.J. , April 24, 2019 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will host a review of its Pharmaceutical businesses for the investment community beginning at 8:30 a.m. (Eastern Time) on Wednesday , May 15, 2019 at the Hyatt Regency Hotel in New Brunswick, New Jersey , and ending at approximately 2:30 p.m.
Alex Gorsky , Chairman and Chief Executive Officer will provide opening remarks. The event will be hosted by Jennifer Taubert , Executive Vice President, Worldwide Chairman, Pharmaceuticals; and Mathai Mammen , M.D., Ph.D. Global Head, Janssen Research & Development. The meeting will feature presentations from the therapeutic area leaders within the Janssen Research & Development organization, which will be followed by Q&A sessions. In addition, Joe Wolk , Executive Vice President, Chief Financial Officer will provide closing remarks followed by a Q&A session with members of the Executive Committee.
The agenda for the day will be posted on the Investor Relations website on May 10th .
Investors and other interested parties may access this meeting by visiting the Company's website at www.investor.jnj.com for a simultaneous webcast of the presentations.
A replay will be available shortly after the live webcast.
SOURCE Johnson & Johnson